BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6117842)

  • 21. Interaction of alpha-MSH and MIF-I with amphetamine on open-field behavior of rats.
    Sandman CA; Kastin AJ
    Pharmacol Biochem Behav; 1978 Dec; 9(6):759-62. PubMed ID: 34173
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased acquisition of a complex appetitive task after MSH and MIF.
    Stratton LO; Kastin AJ
    Pharmacol Biochem Behav; 1975; 3(5):901-4. PubMed ID: 1801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CNS effects of peripherally administered brain peptides.
    Kastin AJ; Olson RD; Schally AV; Coy DH
    Life Sci; 1979 Jul; 25(5):401-14. PubMed ID: 39214
    [No Abstract]   [Full Text] [Related]  

  • 24. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine.
    Banks WA; Kastin AJ
    Peptides; 1994 Jan; 15(1):23-9. PubMed ID: 7912427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
    Banks WA; Kastin AJ; Ehrensing CA
    J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effect of aluminum on the blood-brain barrier transport of peptides, technetium and albumin.
    Banks WA; Kastin AJ; Fasold MB
    J Pharmacol Exp Ther; 1988 Feb; 244(2):579-85. PubMed ID: 2894456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of the acetylcholine-and histamine-induced changes in the permeability of the blood-brain barrier of normotensive and spontaneously hypertensive rats by atropine and pyrilamine.
    Domer FR; Boertje SB; Sweeney SA
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):157-60. PubMed ID: 6648038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
    Mycroft FJ; Wei ET
    Peptides; 1984; 5(5):883-7. PubMed ID: 6150468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impromidine-induced changes in the permeability of the blood-brain barrier of normotensive and spontaneously hypertensive rats.
    Boertje SB; Le Beau D; Ward S
    Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):249-52. PubMed ID: 1975703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of MIF-I, beta-endorphin and alpha-MSH on d-amphetamine induced paradoxical behavioral thermoregulation: possible involvement of the dopaminergic system.
    Yehuda S; Sheleff P
    Peptides; 1985; 6(2):189-92. PubMed ID: 2863810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological effects of MIF-1, MSH, and opiate peptides in clinical studies.
    Kastin AJ; Ehrensing RH; Olson RD; Coy DH
    Int J Neurol; 1980; 14(2-4):205-9. PubMed ID: 6152908
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CNS and pituitary effects of hypothalamic peptides and MSH.
    Kastin AJ; Miller LH; Sandman CA; Schally AV; Plotnikoff NP
    Essays Neurochem Neuropharmacol; 1977; 1():139-76. PubMed ID: 30623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation of changes in the permeability of the blood-brain barrier from catecholamine-induced changes in blood pressure of normotensive and spontaneously hypertensive rats.
    Sankar R; Domer FR; Taylor B
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):343-54. PubMed ID: 7178648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.
    Pan W; Kastin AJ
    Peptides; 2007 Dec; 28(12):2411-34. PubMed ID: 17988762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A brain-to-blood carrier-mediated transport system for small, N-tyrosinated peptides.
    Banks WA; Kastin AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):943-6. PubMed ID: 6151670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twenty-one hormones fail to inhibit the brain to blood transport system for Tyr-MIF-1 and the enkephalins in mice.
    Banks WA; Kastin AJ
    J Pharm Pharmacol; 1988 Apr; 40(4):289-91. PubMed ID: 2900314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of Tyr-MIF-1 to isolated brain capillaries.
    Pretorius HT; Kastin AJ; Banks WA
    Brain Res Bull; 1986 Dec; 17(6):829-31. PubMed ID: 2879616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptides readily penetrate the blood-brain barrier: uptake of peptides by synaptosomes is passive.
    Greenberg R; Whalley CE; Jourdikian F; Mendelson IS; Walter R; Nikolics K; Coy DH; Schally AV; Kastin AJ
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):151-8. PubMed ID: 13414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of histamine-stimulated alterations in cerebrovascular permeability by the H2-receptor antagonist cimetidine.
    Boertje SB; Le Beau D; Williams C
    Neuropharmacology; 1989 Jul; 28(7):749-52. PubMed ID: 2569692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.